Youcare Pharmaceutical Group Co Ltd Class A 688658
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥17.28
- Day Range
- ¥18.43–20.60
- 52-Week Range
- ¥11.99–23.79
- Bid/Ask
- ¥20.35 / ¥20.36
- Market Cap
- ¥9.16 Bil
- Volume/Avg
- 10.7 Mil / 3.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 138.19
- Price/Sales
- 1.99
- Dividend Yield (Trailing)
- 1.16%
- Dividend Yield (Forward)
- 1.16%
- Total Yield
- 1.16%
Company Profile
Youcare Pharmaceutical Group Co Ltd is a pharmaceutical group enterprise integrating new drug research and development, drug production, circulation and sales.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Value
- Total Number of Employees
- 3,179
- Website
- http://www.youcareyk.com
Comparables
Valuation
|
Metric
|
688658
|
688189
|
300966
|
|---|---|---|---|
Price/Earnings (Normalized) | 138.19 | — | 500.00 |
Price/Book Value | 2.18 | 1.34 | 1.94 |
Price/Sales | 1.99 | 4.15 | 3.61 |
Price/Cash Flow | 21.18 | 14.50 | 34.64 |
Price/Earnings
688658
688189
300966
Financial Strength
|
Metric
|
688658
|
688189
|
300966
|
|---|---|---|---|
Quick Ratio | 1.35 | 4.18 | 0.66 |
Current Ratio | 1.82 | 4.40 | 1.22 |
Interest Coverage | 6.92 | −2.93 | 0.47 |
Quick Ratio
688658
688189
300966
Profitability
|
Metric
|
688658
|
688189
|
300966
|
|---|---|---|---|
Return on Assets (Normalized) | 0.83% | −1.65% | 0.13% |
Return on Equity (Normalized) | 1.36% | −2.15% | 0.32% |
Return on Invested Capital (Normalized) | 1.16% | −1.82% | 0.69% |
Return on Assets
688658
688189
300966
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Rnxkzvdyyf | Cgwsh | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Yrdcjjzz | Jdgpxk | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Rxljrtp | Qznhrpk | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Clgwksb | Pwcjv | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Zzkplhc | Vxjb | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Mxqjcvvf | Zhpz | $28.1 Bil | |||
| Moderna Inc
MRNA
| Dxbkjmtx | Gpv | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Rmnhkxmgk | Hpj | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Jytzkbhk | Xjxmnbv | $13.4 Bil | |||
| Incyte Corp
INCY
| Tggthyzf | Fltyyk | $12.7 Bil |
United States